CoChat

Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results

Open access
Moreno–Grau, Sonia, Rodríguez‐Gómez, Octavio, Sanabria, Ángela, Pérez‐Cordón, Alba, Sánchez‐Ruiz, Domingo, Abdelnour, Carla, Valero, Sergi, Hernández, Isabel, Rosende‐Roca, Maitée, Mauleón, Ana, Vargas, Liliana, Lafuente, Asunción, Gil, Silvia, Santos‐Santos, Miguel Ángel, Alegret, Montserrat, Espinosa, Ana, Ortega, Gemma, Guitart, Marina, Gailhajanet, Anna, de Rojas, Itziar, Sotolongo‐Grau, Óscar, Ruiz, Susana, Aguilera, Nuria, Papasey, Judith, Martín, Elvira, Peleja, Esther, Alzheimer's Disease Neuroimaging Initiative, Lomeña, Francisco, Campos, Francisco, Vivas, Assumpta, Gómez‐Chiari, Marta, Tejero, Miguel Ángel, Giménez, Joan, Serrano‐Ríos, Manuel, Orellana, Adelina, Tárraga, Lluís, Ruiz, Agustín, Boada, Mercè, FACEHBI study group, Abdelnour, C., Aguilera, N., Alegret, M., Berthier, M., Boada, M., Buendia, M., Bullich, S., Campos, F., Cañabate, P., Cuevas, C., de Rojas, I., Espinosa, A., Gailhajenet, A., Diego, S., Gil, S., Giménez, J., Gismondi, R., Gómez‐Chiari, M., Guitart, M., Hernández‐Olasagarre, B., Hernández, I., Ibarria, M., Lafuente, A., Lomeña, F., Martín, E., Martínez, J., Mauleón, A., Monté, G., Moreno, M., Moreno‐Grau, S., Núñez, L., Orellana, A., Ortega, G., Páez, A., Pancho, A., Pavía, J., Pelejà, E., Pérez‐Cordon, A., Pérez‐Grijalba, V., Pesini, P., Preckler, S., Rodríguez‐Gómez, O., Romero, J., Rosende‐Roca, M., Ruiz, A., Ruiz, S., Sanabria, A., Sánchez‐Ruiz, D., Santos‐Santos, M.A., Sarasa, M., Sotolongo‐Grau, O., Tárraga, L., Tejero, M.A., Torres, M., Valero, S., Vargas, L., Vivas, A. · 2018 · Alzheimer's & Dementia
Cited by 41

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Introduction: Subjective cognitive decline (SCD) has been proposed as a potential preclinical stage of Alzheimer's disease (AD). Nevertheless, the genetic and biomarker profiles of SCD individuals remain mostly unexplored. Methods: We evaluated apolipoprotein E (APOE) ε4's effect in the risk of presenting SCD, using the Fundacio ACE Healthy Brain Initiative (FACEHBI) SCD cohort and Spanish controls, and performed a meta‐analysis addressing the same question. We assessed the relationship between APOE dosage and brain amyloid burden in the FACEHBI SCD and Alzheimer's Disease Neuroimaging Initiative cohorts. Results: Analysis of the FACEHBI cohort and the meta‐analysis demonstrated SCD individuals presented higher allelic frequencies of APOE ε4 with respect to controls. APOE dosage explained 9% (FACEHBI cohort) and 11% (FACEHBI and Alzheimer's Disease Neuroimaging Initiative cohorts) of the variance of cerebral amyloid levels. Discussion: The FACEHBI sample presents APOE ε4 enrichment, suggesting that a pool of AD patients is nested in our sample. Cerebral amyloid levels are partially explained by the APOE allele dosage, suggesting that other genetic or epigenetic factors are involved in this AD endophenotype.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2017.10.005

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 34

  1. 10.1016/S1474-4422(09)70299-6 · DOI · Paper page
  2. 10.1016/S1474-4422(12)70291-0 · DOI · Paper page
  3. 10.1126/science.8346443 · DOI · Paper page
  4. Moreno‐Grau S, 2016, Genome research in pre‐dementia stages of Alzheimer's disease, Expert Rev Mol Med, 18, e11, 10.1017/erm.2016.12 · DOI
  5. 10.1016/j.neurobiolaging.2010.09.003 · DOI
  6. 10.1016/S0197-4580(01)00254-8 · DOI
  7. 10.1016/S0140-6736(06)69113-7 · DOI · Paper page
  8. 10.1038/mp.2013.19 · DOI · Paper page
  9. 10.1016/S1474-4422(13)70044-9 · DOI · Paper page
  10. 10.1016/j.jalz.2015.03.003 · DOI · Paper page
  11. Rodriguez‐Gomez O, 2017, FACEHBI: A prospective study of risk factors, biomarkers and cognition in a cohort of individuals with subjective cognitive decline. Study rationale and research protocols, J Prev Alz Dis, 4, 100
  12. 10.1371/journal.pone.0076436 · DOI
  13. 10.1001/archneur.56.3.303 · DOI · Paper page
  14. 10.1111/j.1365-2796.2004.01388.x · DOI · Paper page
  15. 10.1001/archneur.64.3.416 · DOI · Paper page
  16. 10.1038/mp.2013.86 · DOI · Paper page
  17. Martínez‐Larrad MT, 2005, [Prevalence of the metabolic syndrome (ATP‐III criteria). Population‐based study of rural and urban areas in the Spanish province of Segovia], Med Clin (Barc), 125, 481
  18. 10.1161/hy0202.103439 · DOI
  19. 10.1016/j.jalz.2010.03.007 · DOI · Paper page
  20. 10.1016/j.jalz.2010.03.003 · DOI · Paper page
  21. 10.1086/519795 · DOI · Paper page
  22. 10.1001/archgenpsychiatry.2010.30 · DOI · Paper page
  23. 10.1016/j.jalz.2011.03.003 · DOI · Paper page
  24. 10.1038/jcbfm.2015.85 · DOI
  25. 10.1161/01.STR.0000259816.31370.44 · DOI · Paper page
  26. 10.1038/nrneurol.2015.10 · DOI · Paper page
  27. 10.3233/JAD-150189 · DOI · Paper page
  28. Abdulrab K, 2008, Subjective memory impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria, Eur Psychiatry, 23, 10.1016/j.eurpsy.2008.02.004 · DOI · Paper page
  29. Zwan MD, 2015, Subjective memory complaints in APOE ɛ4 carriers are associated with high amyloid‐β burden, J Alzheimers Dis, 49
  30. 10.1016/j.jalz.2016.06.093 · DOI
  31. 10.2967/jnumed.115.161893 · DOI
  32. 10.3233/JAD-160667 · DOI
  33. 10.1212/WNL.57.12.2217 · DOI · Paper page
  34. 10.1016/j.jagp.2014.07.009 · DOI

Cited by

See all 41

Metadata

Authors
Moreno–Grau, S., Rodríguez‐Gómez, O., Sanabria, Á., Pérez‐Cordón, A., Sánchez‐Ruiz, D., Abdelnour, C., Valero, S., Hernández, I., Rosende‐Roca, M., Mauleón, A., Vargas, L., Lafuente, A., Gil, S., Santos‐Santos, M. Á., Alegret, M., Espinosa, A., Ortega, G., Guitart, M., Gailhajanet, A., de Rojas, I., Sotolongo‐Grau, Ó., Ruiz, S., Aguilera, N., Papasey, J., Martín, E., Peleja, E., Initiative, A. D. N., Lomeña, F., Campos, F., Vivas, A., Gómez‐Chiari, M., Tejero, M. Á., Giménez, J., Serrano‐Ríos, M., Orellana, A., Tárraga, L., Ruiz, A., Boada, M., FACEHBI study group, Abdelnour, C., Aguilera, N., Alegret, M., Berthier, M., Boada, M., Buendia, M., Bullich, S., Campos, F., Cañabate, P., Cuevas, C., de Rojas, I., Espinosa, A., Gailhajenet, A., Diego, S., Gil, S., Giménez, J., Gismondi, R., Gómez‐Chiari, M., Guitart, M., Hernández‐Olasagarre, B., Hernández, I., Ibarria, M., Lafuente, A., Lomeña, F., Martín, E., Martínez, J., Mauleón, A., Monté, G., Moreno, M., Moreno‐Grau, S., Núñez, L., Orellana, A., Ortega, G., Páez, A., Pancho, A., Pavía, J., Pelejà, E., Pérez‐Cordon, A., Pérez‐Grijalba, V., Pesini, P., Preckler, S., Rodríguez‐Gómez, O., Romero, J., Rosende‐Roca, M., Ruiz, A., Ruiz, S., Sanabria, A., Sánchez‐Ruiz, D., Santos‐Santos, M. A., Sarasa, M., Sotolongo‐Grau, O., Tárraga, L., Tejero, M. A., Torres, M., Valero, S., Vargas, L., & Vivas, A.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2017-11-20
Volume
14
Issue
5
Pages
634-643
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2769567977
Cited by
41
References
14
FWCI
2.19
Type
journal article
Language
en
Open access
hybrid
Funders
  • Alzheimer's Disease Neuroimaging Initiative (U01 AG024904)
  • U.S. Department of Defense (W81XWH‐12‐2‐0012)
  • National Institute on Aging
  • National Institute of Biomedical Imaging and Bioengineering
  • Canadian Institutes of Health Research
  • Northern California Institute for Research and Education

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results. https://app.cochat.ai/papers/10.1016/j.jalz.2017.10.005
The paper
Moreno–Grau, S., Rodríguez‐Gómez, O., Sanabria, Á., Pérez‐Cordón, A., Sánchez‐Ruiz, D., Abdelnour, C., Valero, S., Hernández, I., Rosende‐Roca, M., Mauleón, A., Vargas, L., Lafuente, A., Gil, S., Santos‐Santos, M. Á., Alegret, M., Espinosa, A., Ortega, G., Guitart, M., Gailhajanet, A., . . . Vivas, A. (2018). Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2017.10.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.